Skip to content
10-Q

Quarterly Report

Alterola Biotech, Inc.

0001663577-23-000546

← back to feed
Filed
Nov 21, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Nov 11, 2023 1.37B sh
Stock Repurchased Q2 2024 · Sep 30, 2023 −$44.06K
Stock Repurchased Q2 2024 · Sep 30, 2022 $50.28K
Stockholders Equity Q2 2024 · Sep 30, 2023 −$2.02M
Stockholders Equity Q2 2024 · Sep 30, 2022 $10.75M
Stockholders Equity Q2 2024 · Mar 31, 2022 $11.06M
Current Liabilities Q2 2024 · Sep 30, 2023 $2.52M
Current Liabilities Q2 2024 · Mar 31, 2023 $2.13M
Total Liabilities Q2 2024 · Sep 30, 2023 $2.52M
Total Liabilities Q2 2024 · Mar 31, 2023 $2.28M
Current Assets Q2 2024 · Sep 30, 2023 $197.21K
Current Assets Q2 2024 · Mar 31, 2023 $237.18K
Total Assets Q2 2024 · Sep 30, 2023 $497.21K
Total Assets Q2 2024 · Mar 31, 2023 $12.38M
Operating Cash Flow Q2 2024 · Sep 30, 2022 −$363.21K
Sga Expense Q2 2024 · Sep 30, 2022 $24.16K
Sga Expense Q2 2024 · Sep 30, 2022 $56.82K
Rd Expense Q2 2024 · Sep 30, 2022 $22.61K
Rd Expense Q2 2024 · Sep 30, 2022 $41.09K
Net Income Q2 2024 · Sep 30, 2022 −$375.25K
Net Income Q2 2024 · Sep 30, 2022 −$1.19M
Operating Income Q2 2024 · Sep 30, 2022 −$470.68K
Operating Income Q2 2024 · Sep 30, 2022 −$1.28M